These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 9829742

  • 1. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB, Iversen OE, Akslen LA.
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
    Lundin J, Nordling S, von Boguslawsky K, Roberts PJ, Haglund C.
    Anticancer Res; 1995 Nov; 15(6B):2659-68. PubMed ID: 8669843
    [Abstract] [Full Text] [Related]

  • 3. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis.
    Salvesen HB, Das S, Akslen LA.
    Clin Cancer Res; 2000 Jan; 6(1):153-9. PubMed ID: 10656444
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M, Rudlowski C, Biesterfeld S, Rath W, Schröder W.
    Zentralbl Gynakol; 2000 Jan; 122(7):361-7. PubMed ID: 10951706
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 12. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
    Li SS, Xue WC, Khoo US, Ngan HY, Chan KY, Tam IY, Chiu PM, Ip PP, Tam KF, Cheung AN.
    Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
    [Abstract] [Full Text] [Related]

  • 13. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
    Stefansson IM, Salvesen HB, Immervoll H, Akslen LA.
    Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995
    [Abstract] [Full Text] [Related]

  • 14. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
    Backe J, Gassel AM, Müller T, Schön S, Kaesemann H.
    Zentralbl Gynakol; 1997 May; 119(7):334-42. PubMed ID: 9340973
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
    Mell LK, Meyer JJ, Tretiakova M, Khramtsov A, Gong C, Yamada SD, Montag AG, Mundt AJ.
    Clin Cancer Res; 2004 Aug 15; 10(16):5546-53. PubMed ID: 15328195
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma.
    Khouja MH, Baekelandt M, Nesland JM, Holm R.
    Int J Gynecol Pathol; 2007 Oct 15; 26(4):418-25. PubMed ID: 17885492
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
    Pfisterer J, Kommoss F, Sauerbrei W, Rendl I, Kiechle M, Kleine W, Pfleiderer A.
    Gynecol Oncol; 1995 Aug 15; 58(2):149-56. PubMed ID: 7622098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.